Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures
Clinical trial NCT00957684 · COMPLETED
Trial details
- NCT number
- NCT00957684
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2005-11-01
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.